BG Medicine, Inc.
BGMDOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1137
P/E Ratio—
52W High$0.0001
52W Low$0.0001
BG Medicine, Inc. (BGMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BGMD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2016Report Date: Apr 4, 2016EPS Actual
-$0.08
Revenue
—
Fiscal Period
Q2 FY2016
FY ends December
Report Date
Apr 4, 2016
After Market Close
✓ 3-Quarter EPS Beat Streak
BGMD reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2016 | Apr 4, 2016 | — | -$0.08 | — | — | — | — |
| — Q4 FY2015 | Nov 17, 2015 | — | -$0.27 | — | $0.00B | — | — |
| — Q3 FY2015 | Sep 30, 2015 | — | -$0.10 | — | $0.00B | — | — |
| — Q3 FY2015 | Aug 14, 2015 | — | -$0.23 | — | $0.00B | — | — |
| — Q2 FY2015 | May 14, 2015 | — | -$0.16 | — | $0.00B | — | — |
| — Q4 FY2014 | Dec 31, 2014 | — | -$0.15 | — | $0.00B | — | — |
| — Q4 FY2014 | Nov 13, 2014 | — | -$0.28 | — | $0.00B | — | — |
| — Q3 FY2014 | Aug 14, 2014 | -$0.24 | -$0.24 | +0.0% | $0.00B | — | — |
Q2 FY2016
Apr 4, 2016
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2015
Nov 17, 2015
EPS Actual
-$0.27
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2015
Sep 30, 2015
EPS Actual
-$0.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2015
Aug 14, 2015
EPS Actual
-$0.23
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2015
May 14, 2015
EPS Actual
-$0.16
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2014
Dec 31, 2014
EPS Actual
-$0.15
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2014
Nov 13, 2014
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2014
Aug 14, 2014
EPS Actual
-$0.24
EPS Est.
-$0.24
EPS Surpr.
+0.0%
Revenue
$0.00B
No analyst estimates available for BGMD.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2016 | Apr 4, 2016 | — | $0.20 | $0.19 | -5.13% |
| — Q4 FY2015 | Nov 17, 2015 | — | $0.67 | $0.58 | -14.18% |
| — Q3 FY2015 | Sep 30, 2015 | — | $0.40 | $0.41 | +2.53% |
| — Q3 FY2015 | Aug 14, 2015 | — | $0.93 | $0.83 | -10.66% |
| — Q2 FY2015 | May 14, 2015 | — | $2.72 | $2.40 | -11.62% |
| — Q4 FY2014 | Dec 31, 2014 | — | $2.08 | $1.84 | -11.35% |
| — Q4 FY2014 | Nov 13, 2014 | — | $1.88 | $1.80 | -4.17% |
| ▲ Q3 FY2014 | Aug 14, 2014 | +0.0% | $3.76 | $2.92 | -22.33% |
Q2 FY2016-5.13%
Report Date
Apr 4, 2016
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.19
Q4 FY2015-14.18%
Report Date
Nov 17, 2015
EPS Beat/Miss
—
Price Before
$0.67
Price After
$0.58
Q3 FY2015+2.53%
Report Date
Sep 30, 2015
EPS Beat/Miss
—
Price Before
$0.40
Price After
$0.41
Q3 FY2015-10.66%
Report Date
Aug 14, 2015
EPS Beat/Miss
—
Price Before
$0.93
Price After
$0.83
Q2 FY2015-11.62%
Report Date
May 14, 2015
EPS Beat/Miss
—
Price Before
$2.72
Price After
$2.40
Q4 FY2014-11.35%
Report Date
Dec 31, 2014
EPS Beat/Miss
—
Price Before
$2.08
Price After
$1.84
Q4 FY2014-4.17%
Report Date
Nov 13, 2014
EPS Beat/Miss
—
Price Before
$1.88
Price After
$1.80
Q3 FY2014-22.33%
Report Date
Aug 14, 2014
EPS Beat/Miss
+0.0%
Price Before
$3.76
Price After
$2.92
Avg Beat Reaction-22.33%
Beat Rate1 / 8 quarters
Largest Move-22.33% (Q3 FY2014)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BGMD ends December
BG Medicine, Inc. (BGMD) most recently reported earnings on April 4, 2016 for Q2 FY2016, posting EPS of $-0.08 (in line with the analyst consensus of —). BGMD has beaten EPS estimates for 3 consecutive quarters. The next BGMD earnings date is expected around September 1, 2026.
Each quarter, investors track BGMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BGMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BGMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BGMD earnings · 4 questionsBG Medicine, Inc.'s next earnings report is expected around September 1, 2026. BGMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BGMD historically reports after market close (AMC).
BGMD earnings datewhen is BGMD earningsBGMD next earnings datewhen does BGMD report earningsBGMD earnings calendar
▸ Source: FMP · BG Medicine, Inc. SEC filings · US GAAP · BG Medicine, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026